BioStock: Elicera Therapeutics receives important EU patent

The European Patent Office intends to grant Elicera’s patent application regarding the use of the company’s iTANK technology in CAR T-cell therapies. In a comment to BioStock, the company’s CEO Jamal El-Mosleh says that the patent is an important step forward in the ongoing commercialisation process.

Read the article at biostock.se:

https://www.biostock.se/en/2023/07/elicera-therapeutics-receives-important-eu-patent/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/